Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sevoflurane PK in ICU Patients With Acute Kidney Injury
NCT02042599Phase 2Unknown
- Sponsor
- Centre Hospitalier Universitaire de Clermont-Ferrand
- Start
- Jan 2014
- Primary completion
- Feb 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of sevoflurane, sponsored by Centre Hospitalier Universitaire de Clermont-Ferrand. Primary endpoint: Plasmatic concentrations of sevoflurane. Status: unknown.
02
Drugs
sevoflurane
Beyond the preview
Go deeper on NCT02042599.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02042599.